{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:19:22Z","timestamp":1784074762422,"version":"3.55.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T00:00:00Z","timestamp":1324339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001429","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T21:57:16Z","timestamp":1324418236000},"page":"e1429","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection"],"prefix":"10.1371","volume":"5","author":[{"given":"Saumyabrata","family":"Mazumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithun","family":"Maji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrmicro981","article-title":"Leishmaniasis.","volume":"2","author":"P Desjeux","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty.","volume":"22","author":"J Alvar","year":"2006","journal-title":"Trends Parasitol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"F Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"<italic>Leishmania<\/italic> vaccines: progress and problems.","volume":"133:","author":"L Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1371\/journal.pntd.0000943","article-title":"Vaccines for the leishmaniases: proposals for a research agenda.","volume":"5","author":"CH Costa","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.4049\/jimmunol.167.12.6967","article-title":"Immune elimination of <italic>Leishmania major<\/italic> in mice: implications for immune memory, vaccination, and reactivation disease.","volume":"167","author":"JE Uzonna","year":"2001","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.vaccine.2010.05.077","article-title":"Repeated inoculation of killed <italic>Leishmania major<\/italic> induces durable immune response that protects mice against virulent challenge.","volume":"28","author":"I Okwor","year":"2010","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/IAI.00611-07","article-title":"gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB\/c mice infected with <italic>Leishmania donovani<\/italic>.","volume":"76","author":"S Bhowmick","year":"2008","journal-title":"Infect Immun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2009.09.018","article-title":"Comparison of liposome based antigen delivery systems for protection against <italic>Leishmania donovani<\/italic>.","volume":"141","author":"S Bhowmick","year":"2010","journal-title":"J Control Release"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1128\/IAI.01739-07","article-title":"Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against <italic>Leishmania donovani<\/italic> infection.","volume":"77","author":"S Bhowmick","year":"2009","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/IAI.58.10.3233-3241.1990","article-title":"Characterization of <italic>Leishmania major<\/italic> antigen-liposomes that protect BALB\/c mice against cutaneous leishmaniasis.","volume":"58","author":"LP Kahl","year":"1990","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e3116","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.","volume":"3","author":"EM Agger","year":"2008","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.4049\/jimmunol.178.6.3721","article-title":"Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection.","volume":"178","author":"J Dietrich","year":"2007","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1073\/pnas.89.1.358","article-title":"Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.","volume":"89","author":"LF Fries","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/S0264-410X(02)00150-0","article-title":"Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg\/AS04, a hepatitis B vaccine with a novel adjuvant.","volume":"20","author":"I Desombere","year":"2002","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant.","volume":"20","author":"YA Skeiky","year":"2002","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/IAI.65.6.2371-2377.1997","article-title":"Adjuvanticity and protective immunity elicited by <italic>Leishmania donovani<\/italic> antigens encapsulated in positively charged liposomes.","volume":"65","author":"F Afrin","year":"1997","journal-title":"Infect Immun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.biochi.2010.07.014","article-title":"The effect of C-terminal domain deletion on the catalytic activity of <italic>Leishmania donovani<\/italic> surface proteinase GP63: Role of Ser446 in proteolysis.","volume":"92","author":"S Mazumder","year":"2010","journal-title":"Biochimie"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor.","volume":"176","author":"K Inaba","year":"1992","journal-title":"J Exp Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1128\/IAI.70.12.6697-6706.2002","article-title":"Characterization of <italic>Leishmania donovani<\/italic> antigens encapsulated in liposomes that induce protective immunity in BALB\/c mice.","volume":"70","author":"F Afrin","year":"2002","journal-title":"Infect Immun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.vaccine.2003.09.030","article-title":"A mixed Th1\/Th2 response elicited by a liposomal formulation of <italic>Leishmania<\/italic> vaccine instructs Th1 responses and resistance to <italic>Leishmania donovani<\/italic> in susceptible BALB\/c mice.","volume":"22","author":"T Mazumdar","year":"2004","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying <italic>Leishmania major<\/italic> in tissues of infected mice.","volume":"7","author":"RG Titus","year":"1985","journal-title":"Parasite Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.1000238","article-title":"Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis.","volume":"185","author":"VS Raman","year":"2010","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1016\/j.vaccine.2009.07.081","article-title":"Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.","volume":"27","author":"SL Baldwin","year":"2009","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/intimm\/dxm147","article-title":"Critical role of dendritic cells in determining the Th1\/Th2 balance upon <italic>Leishmania major<\/italic> infection.","volume":"20","author":"K Suzue","year":"2008","journal-title":"Int Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.189.4.741","article-title":"Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral <italic>Leishmania donovani<\/italic>.","volume":"189","author":"HW Murray","year":"1999","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.42.2.702-707.1983","article-title":"Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.","volume":"42","author":"JP Haldar","year":"1983","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis.","volume":"21","author":"RN Coler","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/107999000312748","article-title":"The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to <italic>Leishmania donovani<\/italic> infection in mice.","volume":"20","author":"J Lehmann","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to <italic>Leishmania donovani<\/italic> infection.","volume":"31","author":"ML Murphy","year":"2001","journal-title":"Eur J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T helper (h)1\/Th2 and <italic>Leishmania<\/italic>: paradox rather than paradigm.","volume":"99","author":"J Alexander","year":"2005","journal-title":"Immunol Lett"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0805532107","article-title":"Delivery of foreign antigens by engineered outer membrane vesicle vaccines.","volume":"107","author":"DJ Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives.","volume":"6","author":"N Gar\u00e7on","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jconrel.2005.10.010","article-title":"Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.","volume":"110","author":"J Kazzaz","year":"2006","journal-title":"J Control Release"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1158\/0008-5472.CAN-04-1691","article-title":"Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.","volume":"64","author":"Y Suzuki","year":"2004","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1016\/j.vaccine.2007.10.028","article-title":"Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB\/c mice.","volume":"25","author":"S Mazumder","year":"2007","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, <italic>Leishmania major<\/italic> stress-inducible protein 1, and <italic>Leishmania<\/italic> elongation initiation factor protects against leishmaniasis.","volume":"70","author":"RN Coler","year":"2002","journal-title":"Infect Immun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells.","volume":"75","author":"RN Coler","year":"2007","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-1-4615-1823-5_21","article-title":"Monophosphoryl lipid A as an adjuvant. Past experiences and new directions.","volume":"6","author":"JT Ulrich","year":"1995","journal-title":"Pharm Biotechnol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1517\/14712598.4.7.1129","article-title":"Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents.","volume":"4","author":"JR Baldridge","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/intimm\/12.6.807","article-title":"The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells.","volume":"12","author":"G De Becker","year":"2000","journal-title":"Int Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/IAI.72.3.1608-1617.2004","article-title":"Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.","volume":"72","author":"L Holten-Andersen","year":"2004","journal-title":"Infect Immun"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1128\/IAI.72.6.3383-3390.2004","article-title":"Mitogenicity of the recombinant mycobacterial 27-kilodalton lipoprotein is not connected to its antiprotective effect.","volume":"72","author":"AH Hovav","year":"2004","journal-title":"Infect Immun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.vaccine.2005.10.046","article-title":"Low-dose intraperitoneal Freund&apos;s adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.","volume":"24","author":"J Oscherwitz","year":"2006","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2180-10-181","article-title":"Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.","volume":"10","author":"R Ravindran","year":"2010","journal-title":"BMC Microbiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1016\/j.vaccine.2007.05.009","article-title":"The role of CpG ODN in enhancement of immune response and protection in BALB\/c mice immunized with recombinant major surface glycoprotein of <italic>Leishmania<\/italic> (rgp63) encapsulated in cationic liposome.","volume":"25","author":"MR Jaafari","year":"2007","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein.","volume":"172","author":"YA Skeiky","year":"2004","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.","volume":"174","author":"J Dietrich","year":"2005","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1517\/17425247.5.7.789","article-title":"Recent developments in leishmaniasis vaccine delivery systems.","volume":"5","author":"S Bhowmick","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2006.04.062","article-title":"Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB\/c mice.","volume":"24","author":"MR Jaafari","year":"2006","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11095-010-0301-9","article-title":"Incorporation of the TLR4 agonist monophosphoryl lipid A into the bilayer of DDA\/TDB liposomes: physico-chemical characterization and induction of CD8+ T-cell responses in vivo.","volume":"28","author":"P Nordly","year":"2011","journal-title":"Pharm Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"12793","DOI":"10.1128\/JVI.01519-07","article-title":"The impact of a boosting immunogen on the differentiation of secondary memory CD8<sup>+<\/sup> T cells.","volume":"81","author":"AH Hovav","year":"2007","journal-title":"J Virol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination.","volume":"21","author":"S Lu","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e14644","DOI":"10.1371\/journal.pone.0014644","article-title":"Potency, efficacy and durability of DNA\/DNA,DNA\/protein and protein\/protein based vaccination using gp63 against Leishmania donovani in BALB\/c mice.","volume":"6","author":"S Mazumder","year":"2011","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.4049\/jimmunol.178.6.3721","article-title":"Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection.","volume":"178","author":"J Dietrich","year":"2007","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/intimm\/5.9.1119","article-title":"Dendritic cells and macrophages are required for Th1 development of CD4<sup>+<\/sup> T cells from \u03b1\u03b2 TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-\u03b3 production is IFN-\u03b3-dependent.","volume":"5","author":"SE Macatonia","year":"1993","journal-title":"Int Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1073\/pnas.90.21.10188","article-title":"Interleukin 12 acts directly on CD4<sup>+<\/sup> T cells to enhance priming for interferon \u03b3 production and diminishes interleukin 4 inhibition of such priming.","volume":"90","author":"RA Seder","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.144.12.4794","article-title":"Macrophage killing of <italic>Leishmania<\/italic> parasite in vivo is mediated by nitric oxide from L-arginine.","volume":"144","author":"FY Liew","year":"1990","journal-title":"J Immunol"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:02:26Z","timestamp":1686528146000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001429"}},"subtitle":[],"editor":[{"given":"Rodrigo","family":"Correa-Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,20]]},"references-count":58,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001429","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,20]]}}}